Y10S 530/844
Stomach
Official title: Stomach; intestine
Y10S530/844 (Stomach) appears on 19 US grants and 7 published applications in this corpus.
Search patents in Y10S- Granted patents
- 19
- Published applications
- 7
- Assignees
- 10
- Inventors
- 25
- Latest grant
- 22 May 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 2 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Pharmaceutical compositions for inhibiting intestinal permeability22 May 2012US 8,183,211 B2University of Maryland, Baltimore
- Use of toll-like receptor-expressing cells24 Apr 2012US 8,163,506 B2Meiji Co., Ltd.
- Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes12 May 2009US 7,531,512 B2University of Maryland, Baltimore
- Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes11 Apr 2006US 7,026,294 B2University of Maryland
- Ileus treatment method28 Sep 1999US 5,958,407 AThe Regents of the Uinversity of California
- Method and use of peptide antagonists of zonulin to prevent or delay the onset of diabetes8 May 2014US 2014/0128321 A1University of Maryland, Baltimore
- Method and use of peptide antagonists of zonolin to prevent or delay the onset of diabetes20 Jun 2013US 2013/0157943 A1University of Maryland, Baltimore
- Pharmaceutical compositions for inhibiting intestinal permeability8 Apr 2010US 2010/0087380 A1University of Maryland, Baltimore
- Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes30 Oct 2008US 2008/0269136 A1University of Maryland, Baltimore
- Utilization of Cell Forcibly Expressing Toll-Like Receptor27 Dec 2007US 2007/0298449 A1Meiji Co., Ltd.
Most cited
By later US patents
- Neuropeptide control of ocular growth27US 5,055,302 AThe Trustees of the University of Pennsylvania · 1991
- Immunogenic compositions against human gastrin 1727US 5,468,494 AAphton Corporation · 1995
- Tissue protein PP.sub.4, a process for isolating it and its use25US 4,507,229 ABehringwerke Aktiengesellschaft · 1985
- Substantially pure zonulin, a physiological modulator of mammalian tight junctions25US 5,945,510 AUniversity of Maryland, Baltimore · 1999
- Monoclonal antibodies to mucin-like human differentiation antigens20US 4,863,854 ASloan-Kettering Institute for Cancer Research · 1989